zasocitinib
Takeda
['tak-279', 'derm', '$tak']
this is what $tak is saying about adverse events with tak-279: 53-62% ae rate vs 44% with placebo. most common aes were covid, acne, acneiform dermatitis and diarrhoea. 2 serious aes in 1 pt in the 15mg group, deemed unrelated to tak-279 #aad2023
News Editor for Vantage covering biopharma and medtech; cat lover; banana run winner